$Illumina(ILMN.US) | Piper Sandler ๐ฆ๐๐ข๐ง๐ญ๐๐ข๐ง๐ฌ ๐๐ฏ๐๐ซ๐ฐ๐๐ข๐ ๐ก๐ญ on ๐๐ฅ๐ฅ๐ฎ๐ฆ๐ข๐ง๐, ๐ซ๐๐ข๐ฌ๐๐ฌ ๐๐ ๐ญ๐จ $๐๐๐ ๐๐ซ๐จ๐ฆ $๐๐๐
Analyst sees Illumina decoupling its growth from the volatile academic research market by shifting its revenue mix toward clinical consumables.


